Diabetic Microangiopathy in Ischemic Limb Is a Disease of Disturbance of the Platelet-Derived Growth Factor-BB/Protein Kinase C Axis but Not of Impaired Expression of Angiogenic Factors
Authors:
- 6 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (1) , 55-62
Abstract
Diabetic foot is caused by microangiopathy and is suggested to be a result of impaired angiogenesis. Using a severe hindlimb ischemia model of streptozotocin-induced diabetic mice (STZ-DM), we show that diabetic foot is a disease solely of the disturbance of platelet-derived growth factor B-chain homodimer (PDGF-BB) expression but not responses of angiogenic factors. STZ-DM mice frequently lost their hindlimbs after induced ischemia, whereas non-DM mice did not. Screening of angiogenesis-related factors revealed that only the expression of PDGF-BB was impaired in the STZ-DM mice on baseline, as well as over a time course after limb ischemia. Supplementation of the PDGF-B gene resulted in the prevention of autoamputation, and, furthermore, a protein kinase C (PKC) inhibitor restored the PDGF-BB expression and also resulted in complete rescue of the limbs of the STZ-DM mice. Inhibition of overproduction of advanced-glycation end product resulted in dephosphorylation of PKC-α and restored expression of PDGF-BB irrespective of blood sugar and HbA1c, indicating that advanced-glycation end product is an essential regulator for PKC/PDGF-BB in diabetic state. These findings are clear evidence indicating that diabetic vascular complications are caused by impairment of the PKC/PDGF-B axis, but not by the impaired expression of angiogenic factors, and possibly imply the molecular target of diabetic foot.Keywords
This publication has 28 references indexed in Scilit:
- An MT1-MMP-PDGF receptor-β axis regulates mural cell investment of the microvasculatureGenes & Development, 2005
- Essential Role of PDGFRα-p70S6K Signaling in Mesenchymal Cells During Therapeutic and Tumor Angiogenesis In VivoCirculation Research, 2004
- Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemiaGene Therapy, 2003
- Angiogenic Gene Therapy for Experimental Critical Limb IschemiaCirculation Research, 2002
- Treatment of chronic ulcers in the lower extremities with topical becaplermin gel .01%: A multicenter open-label studyAdvances in Therapy, 2000
- Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic ratsKidney International, 1999
- Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGFThe American Journal of Pathology, 1999
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- Quantitative Electron Microscopic Study of Capillaries in Diabetes mellitusBeiträge zur Pathologie, 1976